Hemoglobin E-beta-thalassemia: Progress report from the international study group

dc.contributor.authorPremawardhena, A.
dc.contributor.authorde Silver, S.
dc.contributor.authorArambepola, M.
dc.contributor.authorOlivieri, N.F.
dc.contributor.authorVichinsky, E.P.
dc.contributor.authorMerson, L.
dc.contributor.authorMuraco, G.
dc.contributor.authorAllen, A.
dc.contributor.authorFisher, C.
dc.contributor.authorPeto, T.
dc.contributor.authorWeatherall, D.J.
dc.date.accessioned2023-07-10T10:14:51Z
dc.date.available2023-07-10T10:14:51Z
dc.date.issued2005
dc.descriptionindexed in MEDLINE.en_US
dc.description.abstractA long-term observational study of Hb E-beta-thalassemia in Sri Lanka is beginning to define some of the genetic and environmental factors that are responsible for its remarkable phenotypic variability. In this population there is a very small difference between the steady-state hemoglobin levels between the mild and severe phenotypes, and it has been possible to stop transfusion in many of those who have been on long-term treatment of this kind. These preliminary observations, made over the last 7 years, provide directions for future research into this increasingly important disease.en_US
dc.identifier.citationAnnals of the New York Academy of Sciences.2005;1054(1):33-9en_US
dc.identifier.issn0077-8923
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/26440
dc.language.isoenen_US
dc.publisherBlackwell Publishingen_US
dc.subjectE-beta-thalassemiaen_US
dc.titleHemoglobin E-beta-thalassemia: Progress report from the international study groupen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
52 B
Format:
Item-specific license agreed upon to submission
Description: